CN105943693A - Traditional Chinese medicinal ointment for treating hyperostosis as well as preparation method and application of traditional Chinese medicinal ointment - Google Patents
Traditional Chinese medicinal ointment for treating hyperostosis as well as preparation method and application of traditional Chinese medicinal ointment Download PDFInfo
- Publication number
- CN105943693A CN105943693A CN201610299582.7A CN201610299582A CN105943693A CN 105943693 A CN105943693 A CN 105943693A CN 201610299582 A CN201610299582 A CN 201610299582A CN 105943693 A CN105943693 A CN 105943693A
- Authority
- CN
- China
- Prior art keywords
- radix
- chinese medicinal
- medicinal ointment
- traditional chinese
- hyperosteogeny
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Withdrawn
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/29—Berberidaceae (Barberry family), e.g. barberry, cohosh or mayapple
- A61K36/296—Epimedium
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/21—Amaranthaceae (Amaranth family), e.g. pigweed, rockwort or globe amaranth
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/23—Apiaceae or Umbelliferae (Carrot family), e.g. dill, chervil, coriander or cumin
- A61K36/232—Angelica
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/23—Apiaceae or Umbelliferae (Carrot family), e.g. dill, chervil, coriander or cumin
- A61K36/237—Notopterygium
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/25—Araliaceae (Ginseng family), e.g. ivy, aralia, schefflera or tetrapanax
- A61K36/258—Panax (ginseng)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/26—Aristolochiaceae (Birthwort family), e.g. heartleaf
- A61K36/268—Asarum (wild ginger)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/27—Asclepiadaceae (Milkweed family), e.g. hoya
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/32—Burseraceae (Frankincense family)
- A61K36/328—Commiphora, e.g. mecca myrrh or balm of Gilead
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/46—Eucommiaceae (Eucommia family), e.g. hardy rubber tree
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/48—Fabaceae or Leguminosae (Pea or Legume family); Caesalpiniaceae; Mimosaceae; Papilionaceae
- A61K36/481—Astragalus (milkvetch)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/48—Fabaceae or Leguminosae (Pea or Legume family); Caesalpiniaceae; Mimosaceae; Papilionaceae
- A61K36/487—Psoralea
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/48—Fabaceae or Leguminosae (Pea or Legume family); Caesalpiniaceae; Mimosaceae; Papilionaceae
- A61K36/488—Pueraria (kudzu)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/54—Lauraceae (Laurel family), e.g. cinnamon or sassafras
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/80—Scrophulariaceae (Figwort family)
- A61K36/804—Rehmannia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
- A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
- A61K2236/30—Extraction of the material
- A61K2236/33—Extraction of the material involving extraction with hydrophilic solvents, e.g. lower alcohols, esters or ketones
- A61K2236/331—Extraction of the material involving extraction with hydrophilic solvents, e.g. lower alcohols, esters or ketones using water, e.g. cold water, infusion, tea, steam distillation, decoction
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
- A61K2236/30—Extraction of the material
- A61K2236/39—Complex extraction schemes, e.g. fractionation or repeated extraction steps
Landscapes
- Health & Medical Sciences (AREA)
- Natural Medicines & Medicinal Plants (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Epidemiology (AREA)
- Alternative & Traditional Medicine (AREA)
- Mycology (AREA)
- Microbiology (AREA)
- Medical Informatics (AREA)
- Botany (AREA)
- Biotechnology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Dermatology (AREA)
- Medicines Containing Plant Substances (AREA)
Abstract
The invention discloses a traditional Chinese medicinal ointment for treating hyperostosis. The traditional Chinese medicinal ointment consists of the following components in percentage by mass: 20-25g of herba epimedii, 20-25g of radix rehmanniae praeparata, 10-15g of eucommia bark, 10-15g of radix astragali, 5-8g of radix achyranthis bidentatae, 10-15g of fructus psoraleae, 5-10g of prepared rhizome of rehmannia, 5-10g of cassia twig, 10-15g of herba asari, 5-10g of radix notoginseng, 3-5g of myrrh, 3-5g of radix puerariae, 5-10g of radix angelicae sinensis and 3-5g of rhizoma seu radix notopterygii. The invention also discloses a preparation method and an application of the traditional Chinese medicinal ointment. The traditional Chinese medicinal ointment disclosed by the invention, on the basis of medicinal values of various components as well as an effect of compatibility of the various components, can be used for effectively removing stasis and expelling evil, eliminating cold and dampness, relaxing muscles and tendons and removing obstruction from meridians; and the traditional Chinese medicinal ointment has the advantages of being good in curative effect and low in cost.
Description
Technical field
The present invention relates to a kind of Chinese medicinal ointment and preparation method thereof and application, a kind of for treating in hyperosteogeny
Ointment and preparation method thereof and application, belong to Chinese medicine formula and applied technical field.
Background technology
Bone matrix hyperplasia is mainly in middle age or old people, dies down mainly due to body constitution after the middle age, and degeneration occurs
Become, and due to work or occupation reason, be chronically at certain given pose, cause flesh stiff, or owing to muscle is by tractive
Or avulsion, wind and cold etc. cause myelosclerosis, form benefit bone, organization of hematoma, form thorn-like or the hyperosteogeny of lip sample.
In prior art, the medicine for the treatment of hyperosteogeny has a variety of, but curative effect is not the most the most satisfactory, it is impossible to realize
The function for the treatment of both the principal and secondary aspects of a disease.
Summary of the invention
In order to solve the problems referred to above, side effect is little, good effect, expense are low to it is an object of the invention to provide one, treatment
Effect significantly for treat hyperosteogeny Chinese medicinal ointment and preparation method thereof and application.
For solving above-mentioned technical problem, the technical scheme is that
A kind of Chinese medicinal ointment for treating hyperosteogeny, it is characterised in that Chinese medicinal ointment formula composition include following components and
The quality proportioning of each component is:
Herba Epimedii: 20-25g；
Radix Rehmanniae Preparata: 20-25g；
The Cortex Eucommiae: 10-15g；
The Radix Astragali: 10-15g；
Radix Achyranthis Bidentatae: 5-8g；
Fructus Psoraleae: 10-15g；
Radix Rehmanniae Preparata: 5-10g；
Ramulus Cinnamomi: 5-10g；
Herba Asari: 10-15g；
Radix Notoginseng: 5-10g；
Myrrha: 3-5g；
Radix Puerariae: 3-5g；
Radix Angelicae Sinensis: 5-10g；
Rhizoma Et Radix Notopterygii: 3-5g.
Further preferably, the formula composition of Chinese medicinal ointment includes that the quality proportioning of following components and each component is: Herba Epimedii:
20g；Radix Rehmanniae Preparata: 20g；The Cortex Eucommiae: 10g；The Radix Astragali: 15g；Radix Achyranthis Bidentatae: 5g；Fructus Psoraleae: 15g；Radix Rehmanniae Preparata: 10g；Ramulus Cinnamomi: 10g；
Herba Asari: 10g；Radix Notoginseng: 5g；Myrrha: 5g；Radix Puerariae: 5g；Radix Angelicae Sinensis: 10g；Rhizoma Et Radix Notopterygii: 5g.
The above-mentioned Chinese medicinal ointment for treating hyperosteogeny, it is also possible to include Cortex Periplocae 5-10g.
Preferably include Cortex Periplocae 5g.
The manufacture method of a kind of Chinese medicinal ointment for treating hyperosteogeny as above, step is: be used for by described
After in the Chinese medicinal ointment for the treatment of hyperosteogeny, each component mixes according to quality proportioning, boiling 3 times, each 1.5-2h, merge and decoct
Liquid, after filtration, the paste of concentration, make plaster, every 5-10g Han crude drug.
Further preferably, every described, plaster 8g Han crude drug.
And, the Chinese medicinal ointment that a kind of preparation method as above prepares is applied to preparation treatment hyperosteogeny medicine
On.
The invention have the benefit that the present invention passes through the medical value of each component in Chinese medicinal ointment, and each other
Compatibility effect, it is possible to effective blood stasis dispelling is got rid of evils, expelling cold and dampness, channels sootheing and network vessel quickening, has the advantage of good effect, low cost.
Detailed description of the invention
Below in conjunction with specific embodiment, the present invention will be described in detail.
As follows for the pharmacology analysis situation of component in Chinese medicinal ointment of the present invention:
Fang Zhong:
The Radix Astragali: property is sweet, tepor, returns lung, spleen, liver, kidney channel, has antibacterial, the function of enhancing human body immunity；
Radix Achyranthis Bidentatae: property is bitter, sour, cool, has effect of warming spleen and stomach for dispelling cold, clearing heat and expelling damp；
Fructus Psoraleae: property is bitter, pungent, warm, returns kidney, spleen channel, is used for treating soreness of the waist and knees cold type of pain；
Radix Rehmanniae Preparata: property is sweet, tepor, returns liver, kidney channel, has effect of yin nourishing of enriching blood, life essence-filling, marrow-benefitting；
Ramulus Cinnamomi: nature and flavor are pungent, sweet, warm, enters lung, the heart, bladder warp, has complement sun, promoting blood circulation, effect of warming the spleen and stomach, treats arthralgia due to cold
Lumbago, has obvious analgesic activity；
Rhizoma Et Radix Notopterygii: warm in nature, acrid in the mouth, hardship, enter bladder, kidney channel, there is relieving exterior syndrome and dispelling cold, expelling wind and dampness, effect of pain relieving；
Herba Epimedii: acrid-sweet flavor is warm in nature, returns Liver and kidney warp, has effect of expelling wind and removing dampness, kidney invigorating and YANG supporting, rheumatic arthralgia；
Radix Rehmanniae Preparata: sweet, tepor.Return liver, kidney channel, be use with Radix Angelicae Sinensis mutual reinforcement between, can treating the liver deficiency of the kidney yin, soreness of the waist and knees, osteopyrexia and fever, increase
Strong immunity；
The Cortex Eucommiae: sweet, temperature.Returning liver, kidney channel, liver and kidney tonifying, bone and muscle strengthening, Chong and Ren Meridians regulating, with Fructus Psoraleae compatibility, warming and recuperating the kidney-YANG power
Increase, hold concurrently spleen reinforcing, liver；
Herba Asari: relieving exterior syndrome and dispelling cold, wind-expelling pain-stopping, sensible, warming the lung to resolve fluid-retention, can drive the cold of internal organs；
Radix Notoginseng: sweet and slightly bitter taste, property is put down, nontoxic, enters liver, stomach, large intestine channel, has dissipating blood stasis, detumescence, effect of analgesic therapy；
Myrrha: bitter in the mouth, flat, nontoxic, enter liver, spleen, the heart, kidney channel, and Flos Carthami compatibility, have invigorate blood circulation, silt of dispelling, stimulate the menstrual flow, the merit of pain relieving
Effect；
Radix Puerariae: yang invigorating expelling pathogenic factors from muscles, anxious to solve person's back；
Radix Angelicae Sinensis: replenishing and activating blood, with Radix Angelicae Pubescentis compatibility, has calmness, analgesia, antibacterial effect；
Cortex Periplocae: acrid in the mouth, hardship, warm in nature, return liver, kidney, heart channel, be used for treating anemofrigid-damp arthralgia, soreness of the waist and knees；
The most all medicines share, and can be effectively improved microcirculation and alleviate local inflammation reaction, and reaching congestion must be capable, and numbness resistance can be led to
Effect, has significant curative effect to treatment hyperosteogeny.
Embodiment 1:
By each component Herba Epimedii: 20g in the described Chinese medicinal ointment being used for treating hyperosteogeny；Radix Rehmanniae Preparata: 20g；The Cortex Eucommiae: 10g；Yellow
Stilbene: 10g；Radix Achyranthis Bidentatae: 5g；Fructus Psoraleae: 10g；Radix Rehmanniae Preparata: 5g；Ramulus Cinnamomi: 5g；Herba Asari: 10g；Radix Notoginseng: 5g；Myrrha: 3g；Radix Puerariae: 3g；
Radix Angelicae Sinensis: 5g；After Rhizoma Et Radix Notopterygii: 3g mixing, boiling 3 times, each 1.5h, collecting decoction, after filtration, the paste of concentration, make
Plaster, every 5g Han crude drug.
Embodiment 2:
By each component Herba Epimedii: 25g in the described Chinese medicinal ointment being used for treating hyperosteogeny；Radix Rehmanniae Preparata: 25g；The Cortex Eucommiae: 15g；
The Radix Astragali: 15g；Radix Achyranthis Bidentatae: 8g；Fructus Psoraleae: 15g；Radix Rehmanniae Preparata: 10g；Ramulus Cinnamomi: 10g；Herba Asari: 15g；Radix Notoginseng: 10g；Not yet
Medicine: 5g；Radix Puerariae: 5g；Radix Angelicae Sinensis: 10g；After Rhizoma Et Radix Notopterygii: 5g mixing, boiling 3 times, each 2h, collecting decoction, after filtration,
The paste of concentration, makes plaster, every 9g Han crude drug.
Embodiment 3:
By each component Herba Epimedii: 20g in the described Chinese medicinal ointment being used for treating hyperosteogeny；Radix Rehmanniae Preparata: 20g；The Cortex Eucommiae: 10g；Yellow
Stilbene: 15g；Radix Achyranthis Bidentatae: 5g；Fructus Psoraleae: 15g；Radix Rehmanniae Preparata: 10g；Ramulus Cinnamomi: 10g；Herba Asari: 10g；Radix Notoginseng: 5g；Myrrha: 5g；Pueraria lobota
Root: 5g；Radix Angelicae Sinensis: 10g；After Rhizoma Et Radix Notopterygii: 5g mixing, boiling 3 times, each 2h, collecting decoction, after filtration, the paste of concentration,
Make plaster, every 6g Han crude drug.
Embodiment 4:
By each component Herba Epimedii: 22g in the described Chinese medicinal ointment being used for treating hyperosteogeny；Radix Rehmanniae Preparata: 22g；The Cortex Eucommiae: 12g；Yellow
Stilbene: 12g；Radix Achyranthis Bidentatae: 6g；Fructus Psoraleae: 12g；Radix Rehmanniae Preparata: 8g；Ramulus Cinnamomi: 8g；Herba Asari: 12g；Radix Notoginseng: 8g；Myrrha: 4g；Radix Puerariae: 4g；
Radix Angelicae Sinensis: 8g；Rhizoma Et Radix Notopterygii: 4g；After Cortex Periplocae 10g mixing, boiling 3 times, each 1.5h, collecting decoction, after filtration, concentrate is thick
Paste, makes plaster, every 8g Han crude drug.
Embodiment 5:
By each component Herba Epimedii: 20g in the described Chinese medicinal ointment being used for treating hyperosteogeny；Radix Rehmanniae Preparata: 20g；The Cortex Eucommiae: 10g；Yellow
Stilbene: 15g；Radix Achyranthis Bidentatae: 5g；Fructus Psoraleae: 15g；Radix Rehmanniae Preparata: 10g；Ramulus Cinnamomi: 10g；Herba Asari: 10g；Radix Notoginseng: 5g；Myrrha: 5g；Pueraria lobota
Root: 5g；Radix Angelicae Sinensis: 10g；Rhizoma Et Radix Notopterygii: 5g；After Cortex Periplocae 5g mixing, boiling 3 times, each 2h, collecting decoction, after filtration, concentrate
Paste, make plaster, every 10g Han crude drug.
For verifying the clinical effectiveness of invention formulation, carry out clinical experiment.
1, case selection standard:
After normal experiment inspection, arthroscopy, bone biopsy, x-ray inspection and the CT examination of hyperosteogeny, there is pass internode
Gap is narrow, osteosclerosis, joint margins come to a point, have hyperosteogeny to be formed, the symptoms such as bone blister cavities can be had all to make under cartilage at heavy burden
For selecting the standard of case.
2, diagnostic criteria
Affected joints can have persistence dull pain, increases the weight of during movable increase, takes a turn for the better after rest, and air pressure increases the weight of when reducing, and can have acute
Panic attacks, has joint stiff sense simultaneously, it is possible to find intraarticular has crunch, and sitting posterior joint is stiff to be increased the weight of, slightly good after activity
Turn, arthroncus, increase and limitation of movement, little complete tetanus, normally behave as bone and block symptoms such as levying.
3, therapeutic scheme
Treatment group 86 example loses money in a business the Chinese medicinal ointment described in inventive embodiments 3, and every day one, 10 days is a course for the treatment of, uses 3 treatments
The logical strength of journey, matched group 89 example sky and bone has an X-rayed patch external application affected part, and every day one, 10 days is a course for the treatment of, uses 3 treatments
Journey, through statistical analysis, two groups of case-datas there was no significant difference (P < 0.05).
4, the evaluation criteria course for the treatment of:
Effective: clinical symptom disappearance, local movement is normal, resumes work, and x-ray checks that hyperosteogeny is controlled；
Taking a turn for the better: clinical symptom remission, local movement is without substantially limiting, and work is slightly by image, and x-ray checks hyperosteogeny limitation, even
There is recurrence；
Invalid: after treating 3 courses for the treatment of, clinic has no alleviation, and x-ray checks that hyperosteogeny is unchanged；
5, therapeutic effect:
Treatment group: effective 45 examples, effective 32 examples, no effect 9, total effective rate is 89.5%；Matched group, effective 24 examples, have
Imitating 46 examples, invalid 19 examples, total effective rate is 78.6%, and treatment group total effective rate, apparently higher than matched group, is specifically shown in Table 1.
1 liang of table group therapeutic effect compares
| Group | Number of cases | Effective | Effectively | Invalid | Total effective rate (%) |
| Treatment group | 86 | 45 | 32 | 9 | 89.5 |
| Matched group | 89 | 24 | 46 | 19 | 78.6 |
As shown in Table 1, the curative effect for the treatment of group, apparently higher than matched group, further relates to Chinese medicinal ointment of the present invention to treatment sclerotin
Hypertrophy has preferable curative effect.
The present invention is by the medical value of each component in Chinese medicinal ointment, and compatibility effect each other, it is possible to validation
The stasis of blood is got rid of evils, expelling cold and dampness, channels sootheing and network vessel quickening, has the advantage of good effect, low cost.
Above detailed description of the invention limits the present invention the most in any form, every in the way of equivalent or equivalent transformation
The technical scheme obtained, all falls within protection scope of the present invention.
Claims (7)
1. the Chinese medicinal ointment being used for treating hyperosteogeny, it is characterised in that the formula composition of Chinese medicinal ointment includes following components
And the quality proportioning of each component is:
Herba Epimedii: 20-25g；
Radix Rehmanniae Preparata: 20-25g；
The Cortex Eucommiae: 10-15g；
The Radix Astragali: 10-15g；
Radix Achyranthis Bidentatae: 5-8g；
Fructus Psoraleae: 10-15g；
Radix Rehmanniae Preparata: 5-10g；
Ramulus Cinnamomi: 5-10g；
Herba Asari: 10-15g；
Radix Notoginseng: 5-10g；
Myrrha: 3-5g；
Radix Puerariae: 3-5g；
Radix Angelicae Sinensis: 5-10g；
Rhizoma Et Radix Notopterygii: 3-5g.
Chinese medicinal ointment for treating hyperosteogeny the most according to claim 1, it is characterised in that the formula composition of Chinese medicinal ointment
The quality proportioning including following components and each component is: Herba Epimedii: 20g；Radix Rehmanniae Preparata: 20g；The Cortex Eucommiae: 10g；The Radix Astragali: 15g；
Radix Achyranthis Bidentatae: 5g；Fructus Psoraleae: 15g；Radix Rehmanniae Preparata: 10g；Ramulus Cinnamomi: 10g；Herba Asari: 10g；Radix Notoginseng: 5g；Myrrha: 5g；Radix Puerariae: 5g；When
Return: 10g；Rhizoma Et Radix Notopterygii: 5g.
Chinese medicinal ointment for treating hyperosteogeny the most according to claim 1 and 2, it is characterised in that also include Cortex Periplocae
5-10g。
Chinese medicinal ointment for treating hyperosteogeny the most according to claim 3, it is characterised in that also include Cortex Periplocae 5g.
5. the manufacture method being used for as claimed in claim 1 treating the Chinese medicinal ointment of hyperosteogeny, it is characterised in that by institute
After each component in the Chinese medicinal ointment treat hyperosteogeny stated mixes according to quality proportioning, boiling 3 times, each 1.5-
2h, collecting decoction, after filtration, the paste of concentration, make plaster, every 5-10g Han crude drug.
The manufacture method of a kind of Chinese medicinal ointment for treating hyperosteogeny the most according to claim 5, it is characterised in that institute
Every, the plaster stated 8g Han crude drug.
7. the Chinese medicinal ointment that a preparation method as claimed in claim 5 prepares is on preparation treatment hyperosteogeny medicine
Application.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201610299582.7A CN105943693A (en) | 2016-05-09 | 2016-05-09 | Traditional Chinese medicinal ointment for treating hyperostosis as well as preparation method and application of traditional Chinese medicinal ointment |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201610299582.7A CN105943693A (en) | 2016-05-09 | 2016-05-09 | Traditional Chinese medicinal ointment for treating hyperostosis as well as preparation method and application of traditional Chinese medicinal ointment |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CN105943693A true CN105943693A (en) | 2016-09-21 |
Family
ID=56914397
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN201610299582.7A Withdrawn CN105943693A (en) | 2016-05-09 | 2016-05-09 | Traditional Chinese medicinal ointment for treating hyperostosis as well as preparation method and application of traditional Chinese medicinal ointment |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN105943693A (en) |
Citations (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1304760A (en) * | 2000-12-14 | 2001-07-25 | 惠留义 | Plaster for treating ostalgia and its preparing process |
-
2016
- 2016-05-09 CN CN201610299582.7A patent/CN105943693A/en not_active Withdrawn
Patent Citations (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1304760A (en) * | 2000-12-14 | 2001-07-25 | 惠留义 | Plaster for treating ostalgia and its preparing process |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN1302805C (en) | Ready prepared Chinese medicine for preventing and treating brain apoplexia | |
| CN102038844B (en) | Chinese medicine composition for treating dilated cardiomyopathy | |
| CN103083556B (en) | Traditional Chinese medicine for treating cervical spondylosis | |
| CN102048893B (en) | Traditional Chinese medicine composition for treating arthromyodynia | |
| CN106266939A (en) | A kind of Chinese medicine composition, the transdermal patch for neck waist rehabilitation comprising this Chinese medicine composition and preparation and application | |
| CN101658657B (en) | Drug for treating chronic cholecystitis | |
| CN102716334B (en) | Chinese medicinal composition for dispelling the cold and removing stasis | |
| CN103751290B (en) | One treats psoriatic pharmaceutical composition | |
| CN102688434B (en) | Traditional Chinese medicine (TCM) for treating diabetes | |
| CN103285203B (en) | Traditional Chinese medicine composition for preventing and treating bone fracture and preparation method thereof | |
| CN103083616B (en) | Traditional Chinese medicine for treating ovarian cyst | |
| CN109453460A (en) | Remedies hot compress moxibustion matrix, Chinese medicine composition and preparation method containing it | |
| CN103720800A (en) | Inflammation-diminishing pain-relieving compound traditional Chinese medicinal composition for treating rheumatic diseases | |
| CN104491146A (en) | Traditional Chinese ointment for treating hyperostosis as well as preparation method and application of traditional Chinese ointment | |
| CN105169279A (en) | Traditional Chinese medicine composition for treating knee joint bone hyperplasia | |
| CN105943693A (en) | Traditional Chinese medicinal ointment for treating hyperostosis as well as preparation method and application of traditional Chinese medicinal ointment | |
| CN104800443A (en) | Bone setting agent with functions of tonifying kidney and regenerating bone marrow | |
| CN104547553A (en) | Traditional Chinese medicine for treating nervous endocrine disorder | |
| CN103948694A (en) | Wind expelling and arthromyodynia dredging traditional Chinese medicine and preparation method thereof | |
| CN104547973A (en) | Health traditional Chinese medicine for treating chest obstruction and preparation method thereof | |
| CN1241580C (en) | Medicinal composition for treating hypersteogeny | |
| CN106492112A (en) | A kind of Chinese medicine formula for treating liver cirrhosis | |
| CN106177785A (en) | A kind of medicine treating cervical spondylosis | |
| CN104758888A (en) | Traditional Chinese medicine composition for treating diabetes | |
| CN104257792B (en) | For treating sick Chinese medicine composition of numbness and preparation method thereof |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| WW01 | Invention patent application withdrawn after publication | ||
| WW01 | Invention patent application withdrawn after publication |
Application publication date: 20160921 |